We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
STAR⋆D study reveals low remission rates in third trial of patients with MDD.
- Authors
Fava, M.; Rush, A. J.; Wisniewski, S. R.; Nierenberg, A. A.; Alpert, J. E.; McGrath, P. J.; Thase, M. E.; Warden, D.; Biggs, M.; Luther, J. F.; Niederehe, G.; Ritz, L.; Trivedi, M. H.
- Abstract
The article reports on the research which reveals that patients with major depressive disorder (MDD) and have failed three trials have low remission rates. The Sequenced Treatment Alterntives to Relieve Depression (STARD), which was funded by the U.S. National Institute of Mental Health, assesses the effectiveness of adequately delivered treatments in outpatients who have MDD includes four levels of treatment. The study states that the course of treatment with each medication in level 3 was similar for both medications. INSET: Editorial cites value of STAR⋆D study.
- Subjects
UNITED States; MENTAL depression; CLINICAL trials; THERAPEUTICS; PATHOLOGICAL psychology; NATIONAL Institute of Mental Health (U.S.)
- Publication
Brown University Psychopharmacology Update, 2006, Vol 17, Issue 9, p1
- ISSN
1068-5308
- Publication type
Article